• Vedantra Collaborates with Neon to Develop Cancer Vaccines
  • FDA Names Potential Merkel Cell Therapy, Using aNK Cells, an Orphan Drug
  • Trial Aimed at Helping Bladder Cancer Patients Choose Immunotherapy or Surgery
  • Protein Known as Moesin Seen as Potential Target for Anti-Cancer Therapy in Early Study
  • Computational Analysis of Immunotherapy Response Paints a Complex Picture
  • Identifying T-Cell Exhaustion Factors May Lead to New Immunotherapy Development
  • T-cells Need Extra Boost After Activation by Immune Checkpoint Inhibitors, Study Shows
  • CEL-SCI Working with FDA to Lift Hold on Phase 3 Trial of Multikine for Head and Neck Cancer
  • Erytech Presents New Data on Employing Red Blood Cells as Cancer Vaccines
  • Infinity to Present Data from Phase 1 Trial of IPI-549 as Treatment for Advanced Solid Tumors
  • Immunostimulatory Protein LIGHT Holds Promise for Colon Cancer Patients with Poor Prognosis
  • Blincyto Found Superior to Standard Chemotherapy in Advanced ALL Patients, According to Phase 3 Trial